Malignant digestive tract tumours such as gastric cancer and colorectal cancer
Conditions
Interventions
Gold Standard:Histopathological diagnosis served as the gold standard for evaluating the novel PET tracer. It provides the definitive diagnosis of malignancy, including type, grade, and stage (AJCC/UI
Index test:1. Standardised Uptake Value (SUV) of the tumour lesion. Image data were acquired during PET scans at 30 minutes and 150 minutes following intravenous injection of the targeted probe. Regio
Sponsors
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1.The subject or his/her legal representative can sign the informed consent form, specifying the signature and date; 2.Commit to abiding by the research procedures and cooperating in the implementation of the entire research process; 3.Adult patients or healthy volunteers (aged 18 or above), regardless of gender; 4.Patients with clinically suspected or confirmed malignant digestive tract tumors such as gastric cancer and colorectal cancer (supporting evidence includes serum-related tumor markers, ultrasound, CT, MRI and other imaging data, and histological pathological examination, etc.), and in good general condition; 5.Conform to the specific laboratory test results; 6.Women of childbearing age should use contraception for at least one month before screening and commit to using contraception throughout the study period and continue until the specified time after the study ends; 7.Other inclusion criteria were set. It was agreed to perform probe imaging targeting digestive tract tumors and 18F-FDG PET imaging;
Exclusion criteria
Exclusion criteria: 1.Acute systemic diseases and electrolyte imbalances; 2.Pregnant women or lactating women who plan to get pregnant within half a year; 3.The patient or his/her legal representative is unable or unwilling to sign the informed consent form;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The ROI of the lesion tissue;SUV value;Lesion volume;ADC value; | — |
Countries
China
Contacts
Public ContactXiaoli Lan
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Outcome results
None listed